If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
42.40    0.00 (0.00%)
Bid:
41.40
Ask:
43.40
Spread: 2.00 (4.831%)
Market Cap: £65.92m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

AGM Results

30 Apr 2014 14:18

RNS Number : 9455F
Maven Income and Growth VCT 3 PLC
30 April 2014
 

 

Maven Income and Growth VCT 3 PLC (the Company) - Result of Annual General Meeting

 

At the Annual General Meeting of the Company held at 1-2 Royal Exchange Buildings, London EC3V 3LF at 10.00am on 30 April 2014, all of the Resolutions put to the Meeting were duly passed. In accordance with the provisions of D.2.2 of the Combined Code on Corporate Governance, the Company advises that for the Annual General Meeting, valid proxy appointments were made in respect of 4,418,229 shares and that the number of proxy votes lodged for each Resolution were as follows:

 

Resolutions

For

Discretion

Against

Withheld

Total

1

To receive the Annual Report and audited Financial Statements

4,168,510

201,640

5,940

42,139

4,418,229

2

To approve the Directors' Remuneration Report

3,943,634

201,640

162,878

110,077

4,418,229

3

To approve the Directors' remuneration policy for the three-year period ending 30 November 2016.

3,890,232

222,300

175,997

129,700

4,418,229

4

To approve a final dividend of 3.25p per ordinary share of 10p each in the capital of the Company (Ordinary Shares) for payment on 30 May 2014 to shareholders on the register at the close of business on 9 May 2014.

4,210,487

201,640

6,102

0

4,418,229

5

To re-elect Mr Michie as a Director

4,100,396

233,402

40,393

44,038

4,418,229

6

To re-elect Mr Nixon as a Director

4,103,242

235,821

38,885

40,281

 

4,418,229

7

To elect Mr Devani as a Director

4,087,110

230,751

33,127

67,241

4,418,229

8

To re-appoint Deloitte LLP as Auditor

 

3,850,813

275,153

242,300

49,963

4,418,229

9

To authorise the Directors to fix the remuneration of the Auditor

4,067,370

274,759

47,965

28,135

4,418,229

10

To authorise the Directors to allot new shares

4,075,578

262,554

41,789

38,308

4,418,229

11

To authorise disapplication of pre-emption rights

3,709,531

267,554

320,113

121,031

4,418,229

12

To authorise the Company to purchase its own shares

3,887,938

241,894

255,072

43,325

4,418,229

13

To allow a General Meeting to be called on not less than 14 days' notice

4,063,604

241,894

77,366

35,365

4,418,229

 

A vote withheld is not a vote in law and any such votes have not been included in the votes for or against the respective Resolutions. The voting figures will be available to view at: www.mavencp.com/migvct3.

 

Passing of Resolutions under Special Business

The Special Resolutions have been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.//hemscott.com/nsm.do.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP, Secretary

30 April 2014

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RAGIMMJTMBBJBRI
Date   Source Headline
1st Apr 202512:59 pmRNSStatement re Offers for Subscription - Closed
27th Mar 20251:11 pmRNSDirector/PDMR Shareholding
27th Mar 20251:06 pmRNSIssue of Equity
27th Mar 202510:25 amRNSUpdate re: Offers for Subscription
24th Mar 20253:53 pmRNSUnaudited Net Asset Value
18th Mar 20253:37 pmRNSAnnual Financial Report
28th Feb 20254:32 pmRNSTransaction in Own Shares
27th Feb 20251:54 pmRNSUnaudited NAV and Proposed Final Dividend
19th Feb 202510:17 amRNSDirector/PDMR Shareholding
19th Feb 202510:14 amRNSDirector/PDMR Shareholding
19th Feb 202510:06 amRNSIssue of Equity
28th Jan 202512:15 pmRNSStatement re Offer for Subscription
18th Dec 20249:35 amRNSIssue of Equity
13th Dec 20242:42 pmRNSNet Asset Value(s)
14th Nov 20242:55 pmRNSResult of General Meeting
25th Oct 20243:49 pmRNSTransaction in Own Shares
27th Sep 20244:31 pmRNSPublication of a Prospectus
6th Sep 202410:25 amRNSDirector/PDMR Shareholding
6th Sep 202410:01 amRNSIssue of Equity
5th Sep 20242:26 pmRNSStatement re Dividend Investment Scheme
5th Sep 20241:40 pmRNSUnaudited Net Asset Value
18th Jul 20245:27 pmRNSHalf-year Report
10th Jul 20245:08 pmRNSTransaction in Own Shares
8th Jul 20244:07 pmRNSStatement re NAV and Interim Dividend
18th Jun 202411:53 amRNSStatement re Intended Offers for Subscription
10th May 20244:11 pmRNSTransaction in Own Shares
3rd May 20249:35 amRNSDirector/PDMR Shareholding
3rd May 20249:33 amRNSIssue of Equity
2nd May 20241:31 pmRNSResult of AGM
1st May 202410:06 amRNSDirector/PDMR Shareholding
1st May 202410:03 amRNSIssue of Equity
26th Apr 20242:40 pmRNSNet Asset Value - Dividend Investment Scheme
19th Apr 202412:17 pmRNSIssue of Supplementary Prospectus
5th Apr 20243:37 pmRNSIssue of Equity
28th Mar 202410:16 amRNSStatement re Offer for Subscription
27th Mar 202410:36 amRNSIssue of Equity
22nd Mar 202410:14 amRNSIssue of Supplementary Prospectus
20th Mar 20243:46 pmRNSUnaudited Net Asset Value
15th Mar 20245:18 pmRNSAnnual Financial Report
21st Feb 20244:24 pmRNSTransaction in Own Shares
8th Feb 202410:30 amRNSDirector/PDMR Shareholding
8th Feb 202410:28 amRNSDirector/PDMR Shareholding
8th Feb 202410:15 amRNSIssue of Equity
6th Feb 202411:07 amRNSDividend Declaration
19th Dec 20233:25 pmRNSIssue of Equity
18th Dec 20235:17 pmRNSUnaudited Net Asset Value
5th Dec 202311:42 amRNSDirectorate Change
9th Nov 20233:47 pmRNSResult of General Meeting
8th Nov 20234:01 pmRNSTransaction in Own Shares
7th Nov 20234:47 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.